283 related articles for article (PubMed ID: 15671063)
1. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
Ma RY; Tong TH; Cheung AM; Tsang AC; Leung WY; Yao KM
J Cell Sci; 2005 Feb; 118(Pt 4):795-806. PubMed ID: 15671063
[TBL] [Abstract][Full Text] [Related]
2. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1.
Ma RY; Tong TH; Leung WY; Yao KM
Methods Mol Biol; 2010; 647():113-23. PubMed ID: 20694663
[TBL] [Abstract][Full Text] [Related]
3. FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.
Lam AK; Ngan AW; Leung MH; Kwok DC; Liu VW; Chan DW; Leung WY; Yao KM
Front Oncol; 2013; 3():11. PubMed ID: 23386997
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 is a downstream target of Gli1 in basal cell carcinomas.
Teh MT; Wong ST; Neill GW; Ghali LR; Philpott MP; Quinn AG
Cancer Res; 2002 Aug; 62(16):4773-80. PubMed ID: 12183437
[TBL] [Abstract][Full Text] [Related]
5. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
6. Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb.
Down CF; Millour J; Lam EW; Watson RJ
Biochim Biophys Acta; 2012 Aug; 1819(8):855-62. PubMed ID: 22513242
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
8. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
9. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.
Li SK; Smith DK; Leung WY; Cheung AM; Lam EW; Dimri GP; Yao KM
J Biol Chem; 2008 Jun; 283(24):16545-53. PubMed ID: 18408007
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
12. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
13. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.
Tsai TT; Guttapalli A; Agrawal A; Albert TJ; Shapiro IM; Risbud MV
J Bone Miner Res; 2007 Jul; 22(7):965-74. PubMed ID: 17371162
[TBL] [Abstract][Full Text] [Related]
14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
16. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and transcriptional repressor activity of HBx on p21(WAF1/Cip1) promoter is regulated by ERK-mediated phosphorylation.
Noh EJ; Jung HJ; Jeong G; Choi KS; Park HJ; Lee CH; Lee JS
Biochem Biophys Res Commun; 2004 Jul; 319(3):738-45. PubMed ID: 15184045
[TBL] [Abstract][Full Text] [Related]
18. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.
Huang C; Xie D; Cui J; Li Q; Gao Y; Xie K
Clin Cancer Res; 2014 Mar; 20(6):1477-88. PubMed ID: 24452790
[TBL] [Abstract][Full Text] [Related]
19. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
[TBL] [Abstract][Full Text] [Related]
20. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
Whitehurst CE; Geppert TD
J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
